128 related articles for article (PubMed ID: 31867282)
1. Accuracy of Nodal Positivity in Inadequate Lymphadenectomy in Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Population Study Using the US SEER Database.
Wang W; Shen Z; Shi Y; Zou S; Fu N; Jiang Y; Xu Z; Chen H; Deng X; Shen B
Front Oncol; 2019; 9():1386. PubMed ID: 31867282
[No Abstract] [Full Text] [Related]
2. Pancreatic ductal adenocarcinoma (PDAC) regional nodal disease at standard lymphadenectomy: is MRI accurate for identifying node-positive patients?
Adham S; Ferri M; Lee SY; Larocque N; Alwahbi OA; Ruo L; van der Pol CB
Eur Radiol; 2023 Sep; 33(9):5976-5983. PubMed ID: 37004569
[TBL] [Abstract][Full Text] [Related]
3. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.
Fu N; Wang W; Cheng D; Wang J; Xu Z; Deng X; Peng C; Chen H; Shen B
Pancreatology; 2021 Jun; 21(4):724-730. PubMed ID: 33642141
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of the extent of axillary nodal positivity related to primary tumor size, number of involved nodes, and number of nodes examined.
Iyer RV; Hanlon A; Fowble B; Freedman G; Nicolaou N; Anderson P; Hoffman J; Sigurdson E; Boraas M; Torosian M
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1177-83. PubMed ID: 10889370
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the lymphadenectomy strategy for elderly pancreatic ductal adenocarcinoma patients undergoing curative-intent resection.
Li Z; Zhang X; Guo C; Sun C; Li Z; Fei H; Chen Y; Zhao D
Am J Cancer Res; 2023; 13(5):1938-1951. PubMed ID: 37293173
[TBL] [Abstract][Full Text] [Related]
6. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.
Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406
[TBL] [Abstract][Full Text] [Related]
7. Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
Malleo G; Maggino L; Qadan M; Marchegiani G; Ferrone CR; Paiella S; Luchini C; Mino-Kenudson M; Capelli P; Scarpa A; Lillemoe KD; Bassi C; Castillo CF; Salvia R
Ann Surg; 2022 Nov; 276(5):e518-e526. PubMed ID: 33177357
[TBL] [Abstract][Full Text] [Related]
8. Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.
Li YF; Xiang YC; Zhang QQ; Wang WL
J Gastrointest Oncol; 2020 Aug; 11(4):644-653. PubMed ID: 32953148
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
[TBL] [Abstract][Full Text] [Related]
10. A Refined Staging Model for Resectable Pancreatic Ductal Adenocarcinoma Incorporating Examined Lymph Nodes, Location of Tumor and Positive Lymph Nodes Ratio.
Song Y; Chen Z; Chen L; He C; Huang X; Duan F; Wang J; Lao X; Li S
J Cancer; 2018; 9(19):3507-3514. PubMed ID: 30310507
[No Abstract] [Full Text] [Related]
11. At least 16 lymph nodes are recommended to examine during pancreaticoduodenectomy in ampullary adenocarcinoma.
Zhang X; Sun C; Zhao L; Niu P; Li Z; Fei H; Wang W; Guo C; Che X; Chen Y; Zhao D
Am J Cancer Res; 2023; 13(1):340-351. PubMed ID: 36777520
[TBL] [Abstract][Full Text] [Related]
12. Should a standard lymphadenectomy include the No. 9 lymph nodes for body and tail pancreatic ductal adenocarcinoma?
Zhou Y; Lin J; Wang W; Chen H; Deng X; Peng C; Cheng D; Shen B
Pancreatology; 2019 Apr; 19(3):414-418. PubMed ID: 30902419
[TBL] [Abstract][Full Text] [Related]
13. Assessing the adequacy of lymph node yield for different tumor stages of colon cancer by nodal staging scores.
Wu Z; Qin G; Zhao N; Jia H; Zheng X
BMC Cancer; 2017 Jul; 17(1):498. PubMed ID: 28743236
[TBL] [Abstract][Full Text] [Related]
14. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
15. Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma.
Vuarnesson H; Lupinacci RM; Semoun O; Svrcek M; Julié C; Balladur P; Penna C; Bachet JB; Resche-Rigon M; Paye F
Eur J Surg Oncol; 2013 Oct; 39(10):1116-21. PubMed ID: 23948704
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer.
Pawlik TM; Abdalla EK; Barnett CC; Ahmad SA; Cleary KR; Vauthey JN; Lee JE; Evans DB; Pisters PW
Arch Surg; 2005 Jun; 140(6):584-9; discussion 589-91. PubMed ID: 15967906
[TBL] [Abstract][Full Text] [Related]
17. Impact of Examined Lymph Node Count on Precise Staging and Long-term Survival After Neoadjuvant Therapy for Carcinoma of the Esophagus: A SEER Database Analysis.
Bao T; Bao L; Guo W
Front Surg; 2022; 9():864593. PubMed ID: 35574562
[TBL] [Abstract][Full Text] [Related]
18. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
19. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
20. The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study.
Chi H; Zhang C; Wang H; Wang Z
Oncotarget; 2017 Sep; 8(39):65668-65676. PubMed ID: 29029462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
